Evaluation of IHC Ki-67 with Clinical Correlation in Psoriasis

1. Dogra S, Yadav S. Psoriasis in India: prevalence and pattern. Indian J Dermatol Venereol Leprol. 2010;76(6): 595-601.10.4103/0378-6323.7244321079301Search in Google Scholar

2. Danielsen K, Olsen AO, Wilsgaard T, Furberg AS. Is the prevalence of psoriasis increasing? A 30–year follow-up of a population–based cohort. Br J Dermatol. 2013;168(6):1303-10.10.1111/bjd.1223023374051Search in Google Scholar

3. Asokan N, Prathap P, Ajithkumar K, Betsy A, Binesh VG. Pattern of psoriasis in a tertiary care teaching hospital in South India. Indian J Dermatol. 2011;56(1):118-9.10.4103/0019-5154.77575308892121572811Search in Google Scholar

4. Sehgal VN, Dogra S, Srivastava G, Aggarwal AK. Psoriasiform dermatoses. Indian J Dermatol Venereol Leprol. 2008;74(2):94-9.10.4103/0378-6323.3968818388363Search in Google Scholar

5. Amin MM, Azim ZA. Immunohistochemical study of osteopontin, Ki-67, and CD34 of psoriasis in Mansoura, Egypt. Indian J Pathol Microbiol. 2012;55(1):56-60.10.4103/0377-4929.9485722499302Search in Google Scholar

6. Pinkus H. Psoriasiform tissue reactions. Aust J Dermatol. 1965;8(1):31-5.10.1111/j.1440-0960.1965.tb01367.x5831190Search in Google Scholar

7. Sezer E, Böer-Auer A, Cetin E, Tokat F, Durmaz E, Sahin S, et al. Diagnostic utility of Ki-67 and Cyclin D1 immunostaining in differentiation of psoriasis vs. other psoriasiform dermatitis. Dermatol Pract Concept. 2015;5(3):7-13.Search in Google Scholar

8. Jun-min Z, Geng-shi H, Chun-hong Z. Expression of P57 (kip2), PCNA and Ki67 in psoriatic lesion. China Tropical Medicine. 2009;9:453-4.Search in Google Scholar

9. Chang SL, Hu S, Hung SI, Huang YL, Hsiao WC, Chung WH. A comparison of Ki-67 antigen presentation in acute generalized exanthematous pustulosis and pustular psoriasis. Arch Dermatol Res. 2010;302 (7) : 525-9.10.1007/s00403-010-1046-320336306Search in Google Scholar

10. Weinstein GD, McCullough JL, Ross PA. Cell kinetic basis for pathophysiology of psoriasis. J Invest Dermatol. 1985;85(6):579-83.10.1111/1523-1747.ep122835944067329Search in Google Scholar

11. Nickoloff BJ, Griffiths CE. Lymphocyte trafficking in psoriasis: a new perspective emphasizing the dermal dendrocyte with active dermal recruitment mediated via endothelial cells followed by intra-epidermal T-cell activation. J Invest Dermatol. 1990;95(5 Suppl):35S-7.10.1111/1523-1747.ep1250573116788628Search in Google Scholar

12. Prakashiny S, Srivastava V. Clinicohistological correlation of psoriasis and immunohistochemical expression of Ki 67. IP Journal of Diagnostic Pathology and Oncology. 2017;2(2):26-31.Search in Google Scholar

13. Abdou AG, Maraee AH, Eltahmoudy M, El-Aziz RA. Immunohistochemical expression of GLUT-1 and Ki-67 in chronic plaque psoriasis. Am J Dermatopathol. 2013; 35(7):731-7.10.1097/DAD.0b013e3182819da623392136Search in Google Scholar

14. Miracco C, Pellegrino M, Flori ML, Vatti R, Materno M, Andreassi L. Cyclin D1, B and A expression and cell turnover in psoriatic skin lesions before and after cyclosporin treatment. Br J Dermatol. 2000;143(5):950-6.10.1046/j.1365-2133.2000.03826.xSearch in Google Scholar

15. Tursen B, Kara T, Tursen U, Apa DD, Gubur O, Kaya TI. The changes in expression of Ki-67, and CD31 in psoriatic lesions before and after etanercept treatment. Hong Kong Journal of Dermatology and Venereology. 2013;21(1):5-13.Search in Google Scholar

16. van der Velden HM, Pasch MC, van Erp PE, van Lingen RG, Otero ME, de Boer-van Huizen RT, et al. Treatment of plaque psoriasis with the two-compound product calcipotriol/betamethasone dipropionate versus both monotherapies: an immunohistochemical study. J Dermatolog Treat. 2010;21(1):13-22.10.3109/09546630903214175Search in Google Scholar

17. Jesionek-Kupnicka D, Chomiczewska-Skóra D, Rotsztejn H. Influence of phototherapy in psoriasis on ki-67 antigen expression: a preliminary study. Pol J Pathol. 2013;64(2):96-103.10.5114/pjp.2013.36006Search in Google Scholar

18. Chen GS, Wu TM, Yang SA, Yu HS. Quantitative assessments of physiological and biological parameters in psoriatic lesions and its correlations to the clinical severit y of psoriasis. K aohsiung J Med Sci. 2001;17(8):408-18.Search in Google Scholar

19. Nast A, Gisondi P, Ormerod AD, Saiag P, Smith C, Spuls PI, et al. European S3-Guidelines on the systemic treatment of psoriasis vulgaris - update 2015 - short version - EDF in cooperation with EADV and IPC. J Eur Acad Dermatol Venereol. 2015;29(12):2277-94.10.1111/jdv.13354Search in Google Scholar

20. Bary AA, Bary AA. Study of keratinocyte proliferation, apoptosis, and dermal inflammation in psoriatic skin lesions before and after methotrexate therapy: which change is contributing more to the clinical severity of the disease? American Journal of Research in Medical Sciences. 2018;2(1):34-43.Search in Google Scholar

21. Yazici AC, Tursen U, Apa DD, Ikizoglu G, Api H, Baz K, et al. The changes in expression of ICAM-3, Ki-67, PCNA, and CD31 in psoriatic lesions before and after methotrexate treatment. Arch Dermatol Res. 2005;297 (6):249-55.10.1007/s00403-005-0602-8Search in Google Scholar

22. Ralfs IG, Dawber RP, Ryan TJ, Wright NA. Pityriasis rubra pilaris: epidermal cell kinetics. Br J Dermatol. 1981;104(3):249-52.10.1111/j.1365-2133.1981.tb00945.xSearch in Google Scholar

23. Chen JF, Gao HW, Wang WM. Juvenile pityriasis rubra pilaris: a case report with immunohistochemical and electromicroscopic studies. Dermatologica Sinica. 2010;28(1):46-50.10.1016/S1027-8117(10)60009-2Search in Google Scholar